Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
| Autor: | Zhenxue Tian, Xu Yang, Jianjun Gao |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Drug
China medicine.medical_specialty Health (social science) Coronavirus disease 2019 (COVID-19) media_common.quotation_subject Pneumonia Viral General Biochemistry Genetics and Molecular Biology Virus Health(social science) Betacoronavirus 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans Multicenter Studies as Topic media_common National health Clinical Trials as Topic SARS-CoV-2 business.industry Drug Repositioning COVID-19 Chloroquine General Medicine medicine.disease Chloroquine Phosphate COVID-19 Drug Treatment Clinical trial Pneumonia 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Coronavirus Infections business Malaria |
| Zdroj: | BioScience Trends |
| ISSN: | 1881-7823 1881-7815 |
| DOI: | 10.5582/bst.2020.01047 |
| Popis: | The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|